{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:09:07Z","timestamp":1792800547907,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Science &Technology of Sichuan Province","award":["14JC0093"],"award-info":[{"award-number":["14JC0093"]}]},{"name":"the Projects of the National Natural Science Foundation of China","award":["81271478"],"award-info":[{"award-number":["81271478"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent studies have shown that circular RNA (circRNA) is rich in microRNA (miRNA) binding sites. We have previously demonstrated that the antidepressant effect of ketamine is related to the abnormal expression of various miRNAs in the brain. This study determined the expression profile of circRNAs in the hippocampus of rats treated with ketamine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The aberrantly expressed circRNAs in rat hippocampus after ketamine injection were analyzed by microarray chip, and we further validated these circRNAs by quantitative reverse-transcription PCR (qRT-PCR). The target genes of the different circRNAs were predicted using bioinformatic analyses, and the functions and signal pathways of these target genes were investigated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Microarray analysis showed that five circRNAs were aberrantly expressed in rat hippocampus after ketamine injection (fold change &gt;\u20092.0,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). The results from the qRT-PCR showed that one of the circRNAs was significantly increased (rno_circRNA_014900; fold change\u2009=\u20092.37;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03), while one was significantly reduced (rno_circRNA_005442; fold change\u2009=\u20090.37;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01). We discovered a significant enrichment in several GO terms and pathways associated with depression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings showed the abnormal expression of ketamine-induced hippocampal circRNAs in rats.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-019-2374-2","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T07:03:07Z","timestamp":1577948587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Abnormal expression of rno_circRNA_014900 and rno_circRNA_005442 induced by ketamine in the rat hippocampus"],"prefix":"10.1186","volume":"20","author":[{"given":"Jing","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-9104","authenticated-orcid":false,"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"issue":"6103","key":"2374_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338(6103):68\u201372.","journal-title":"Science"},{"issue":"2","key":"2374_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","volume":"123","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira R, Salvadore G, Diazgranados N, Zarate CA. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther. 2009;123(2):143\u201350.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"2374_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351\u20134.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"2374_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/YCT.0b013e31824d1d02","volume":"28","author":"XB Wang","year":"2012","unstructured":"Wang XB, Chen YL, Zhou X, Liu F, Zhang T, Zhang C. Effects of propofol and ketamine as the combined anesthesia for electroconvulsive therapy in patients with depressive disorder. J ECT. 2012;28(2):128\u201332.","journal-title":"J ECT"},{"issue":"1","key":"2374_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","volume":"32","author":"LS Garcia","year":"2008","unstructured":"Garcia LS, Comim CM, Valvassori SS, R\u00e9us GZ, Barbosa LM, Andreazza AC, et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol. 2008;32(1):140\u20134.","journal-title":"Prog Neuropsychopharmacol"},{"key":"2374_CR6","doi-asserted-by":"publisher","first-page":"e741","DOI":"10.1038\/tp.2016.21","volume":"6","author":"HL Sun","year":"2016","unstructured":"Sun HL, Zhou ZQ, Zhang GF, Yang C, Wang XM, Shen JC, et al. Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model. Transl Psychiatry. 2016;6:e741.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"2374_CR7","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","volume":"77","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Wang N, Yang C, Shi JY, Yu HY, Hashimoto K. Serum interleukin-6 is a predictive biomarker for ketamine\u2019s antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry. 2015;77(3):e19\u201320.","journal-title":"Biol Psychiatry"},{"issue":"10","key":"2374_CR8","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment resistant major depression: a two-site randomized controlledtrial. Am J Psychiatry. 2013;170(10):1134\u201342.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2374_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s12017-014-8312-z","volume":"16","author":"X Yang","year":"2014","unstructured":"Yang X, Yang Q, Wang X, Luo C, Wan Y, Li J, et al. MicroRNA expression profile and functional analysis reveal that miR-206 is a critical novel gene for the expression of BDNF induced by ketamine. NeuroMolecular Med. 2014;16(3):594\u2013605.","journal-title":"NeuroMolecular Med"},{"key":"2374_CR10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fnmol.2016.00074","volume":"9","author":"D Van Rossum","year":"2016","unstructured":"Van Rossum D, Verheijen BM, Pasterkamp RJ. Circular RNAs: novel regulators of neuronal development. Front Mol Neurosci. 2016;9:74.","journal-title":"Front Mol Neurosci"},{"issue":"7483","key":"2374_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352.","journal-title":"Nature"},{"key":"2374_CR12","first-page":"2549","volume":"20","author":"MZ Wang","year":"2019","unstructured":"Wang MZ, Su PX, Liu Y, Zhang XT, Yan J, An XG, et al. Abnormal expression of circRNA_089763 in the plasma exosomes of patients with post operative cognitive dysfunction after coronary artery bypass grafting. Mol Med Rep. 2019;20:2549\u201362.","journal-title":"Mol Med Rep"},{"issue":"11","key":"2374_CR13","doi-asserted-by":"publisher","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","volume":"10","author":"AJ Ferrari","year":"2010","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study. PLoS Med. 2010;10(11):e1001547.","journal-title":"PLoS Med"},{"issue":"2","key":"2374_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","volume":"20","author":"JW Newcomer","year":"1999","unstructured":"Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, et al. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology. 1999;20(2):106\u201318.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2374_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141\u201357.","journal-title":"RNA"},{"issue":"16","key":"2374_CR16","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2217\/pgs.13.154","volume":"14","author":"K Malki","year":"2013","unstructured":"Malki K, Tosto MG, Jumabhoy I, Lourdusamy A, Sluyter F, Craig I, et al. Integrative mouse and human mRNA studies using WGCNA nominates novel candidate genes involved in the pathogenesis of major depressive disorder. Pharmacogenomics. 2013;14(16):1979\u201390.","journal-title":"Pharmacogenomics"},{"issue":"5","key":"2374_CR17","first-page":"454","volume":"41","author":"J Kim","year":"2018","unstructured":"Kim J, Lee S, Kang S, Jeon TI, Kang MJ, Lee TH, et al. Regulator of G-protein signaling 4 (RGS4) controls morphine reward by glutamate receptor activation in the nucleus Accumbens of mouse brain. Mol Cells. 2018;41(5):454\u201364.","journal-title":"Mol Cells"},{"key":"2374_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2147\/NDT.S155076","volume":"14","author":"D Zeng","year":"2018","unstructured":"Zeng D, He S, Yu S, Li G, Ma C, Wen Y, et al. Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response. Neuropsychiatr Dis Treat. 2018;14:715\u201323.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"20","key":"2374_CR19","doi-asserted-by":"publisher","first-page":"8254","DOI":"10.1073\/pnas.1214696110","volume":"110","author":"M Stratinaki","year":"2013","unstructured":"Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, et al. Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc Natl Acad Sci U S A. 2013;110(20):8254\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2374_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.mp.4000866","volume":"6","author":"K Mirnics","year":"2001","unstructured":"Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry. 2001;6(3):293\u2013301.","journal-title":"Mol Psychiatry"},{"key":"2374_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13148-015-0123-z","volume":"7","author":"D N\u00e4tt","year":"2015","unstructured":"N\u00e4tt D, Johansson I, Faresj\u00f6 T, Ludvigsson J, Thorsell A. High cortisol in 5-year-old children causes loss of DNA methylation in SINE retrotransposons: a possible role for ZNF263 in stress-related diseases. Clin Epigenetics. 2015;7:91.","journal-title":"Clin Epigenetics"},{"issue":"12","key":"2374_CR22","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1517\/17460441.2013.845553","volume":"8","author":"MA Grados","year":"2013","unstructured":"Grados MA, Specht MW, Sung HM, Fortune D. Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach. Expert Opin Drug Discov. 2013;8(12):1515\u201327.","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"2374_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.gene.2016.04.011","volume":"586","author":"LN Douglas","year":"2016","unstructured":"Douglas LN, McGuire AB, Manzardo AM, Butler MG. High-resolution chromosome ideogram representation of recognized genes for bipolar disorder. Gene. 2016;586(1):136\u201347.","journal-title":"Gene"},{"issue":"3","key":"2374_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4306\/pi.2015.12.3.388","volume":"12","author":"L Gao","year":"2015","unstructured":"Gao L, Gao Y, Xu E, Xie J. Microarray analysis of the major depressive disorder mRNA profile data. Psychiatry Investig. 2015;12(3):388\u201396.","journal-title":"Psychiatry Investig"},{"issue":"16","key":"2374_CR25","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/emboj.2013.166","volume":"32","author":"M Benoist","year":"2013","unstructured":"Benoist M, Palenzuela R, Rozas C, Rojas P, Tortosa E, Morales B, et al. MAP 1B- dependent Rac activation is required for AMPA receptor endocytosis during long-term depression. EMBO J. 2013;32(16):2287\u201399.","journal-title":"EMBO J"},{"issue":"2","key":"2374_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/JIN-170052","volume":"17","author":"X Ni","year":"2018","unstructured":"Ni X, Liao Y, Li L, Zhang X, Wu Z. Therapeutic role of long non-coding RNA TCONS_00019174 in depressive disorders is dependent on Wnt\/\u03b2-catenin signaling pathway. J Integr Neurosci. 2018;17(2):203\u201315.","journal-title":"J Integr Neurosci"},{"issue":"2","key":"2374_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/mp.2016.184","volume":"23","author":"PM Martin","year":"2018","unstructured":"Martin PM, Stanley RE, Ross AP, Freitas AE, Moyer CE, Brumback AC, et al. DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt\/\u03b2-catenin signaling. Mol Psychiatry. 2018;23(2):467\u201375.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"2374_CR28","doi-asserted-by":"publisher","first-page":"e892","DOI":"10.1038\/tp.2016.122","volume":"6","author":"WJ Zhou","year":"2016","unstructured":"Zhou WJ, Xu N, Kong L, Sun SC, Xu XF, Jia MZ, et al. The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviors. Transl Psychiatry. 2016;6(9):e892.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"2374_CR29","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1007\/s12035-015-9192-4","volume":"53","author":"MP Cunha","year":"2016","unstructured":"Cunha MP, Budni J, Ludka FK, Pazini FL, Rosa JM, Oliveira \u00c1, Lopes MW, et al. Involvement of PI3K\/Akt signaling pathway and its downstream intracellular targets in the antidepressant-like effect of Creatine. Mol Neurobiol. 2016;53(5):2954\u201368.","journal-title":"Mol Neurobiol"},{"issue":"12","key":"2374_CR30","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1038\/npp.2012.131","volume":"37","author":"HS Shi","year":"2012","unstructured":"Shi HS, Zhu WL, Liu JF, Luo YX, Si JJ, Wang SJ, et al. PI3K\/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3. Neuropsychopharmacology. 2012;37(12):2671\u201383.","journal-title":"Neuropsychopharmacology"},{"key":"2374_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbr.2017.04.015","volume":"329","author":"IVA Lima","year":"2017","unstructured":"Lima IVA, Almeida-Santos AF, Ferreira-Vieira TH, Aguiar DC, Ribeiro FM, Campos AC, et al. Antidepressant-like effect of valproic acid-possible involvement of PI3K\/Akt\/mTOR pathway. Behav Brain Res. 2017;329:166\u201371.","journal-title":"Behav Brain Res"},{"issue":"10","key":"2374_CR32","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.1007\/s12035-015-9580-9","volume":"53","author":"FL Pazini","year":"2016","unstructured":"Pazini FL, Cunha MP, Rosa JM, Colla AR, Lieberknecht V, et al. Creatine, similar to ketamine, counteracts depressive-like behavior induced by Corticosterone via PI3K\/Akt\/mTOR pathway. Mol Neurobiol. 2016;53(10):6818\u201334.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2374_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000356517","volume":"21","author":"W Zhou","year":"2014","unstructured":"Zhou W, Dong L, Wang N, Shi JY, Yang JJ, Zuo ZY, et al. Akt mediates GSK-3\u03b2 phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions. Neuroimmunomodulation. 2014;21(4):183\u20138.","journal-title":"Neuroimmunomodulation"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2374-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-019-2374-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2374-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T19:21:49Z","timestamp":1609442509000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-019-2374-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2374"],"URL":"https:\/\/doi.org\/10.1186\/s12888-019-2374-2","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures involving animals were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the Chinese Society for Neuroscience and Behavior recommendations for animal care. All of the experiments involving surgeries and treatments were approved by the ethics committee of Southwest Medical University (Ethics number: 20180306038).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}